{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T23:03:06Z","timestamp":1787698986483,"version":"build-2784847793"},"reference-count":0,"publisher":"BioExcel","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DIC"],"DOI":"10.7573\/dic.212249","type":"journal-article","created":{"date-parts":[[2013,3,28]],"date-time":"2013-03-28T05:53:01Z","timestamp":1364449981000},"page":"1-12","source":"Crossref","is-referenced-by-count":9,"title":["Therapeutic approaches to slowing the progression of diabetic nephropathy \u2013 is less best?"],"prefix":"10.7573","author":[{"given":"Eva","family":"Vivian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelsea","family":"Mannebach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10047","published-online":{"date-parts":[[2013,3,27]]},"container-title":["Drugs in Context"],"original-title":[],"link":[{"URL":"https:\/\/www.drugsincontext.com\/wp-content\/uploads\/2014\/05\/dic.212249.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,10]],"date-time":"2020-01-10T15:01:41Z","timestamp":1578668501000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.drugsincontext.com\/individual\/therapeutic-approaches-to-slowing-diabetic-nephropathy-e-vivian-212249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,27]]},"references-count":0,"URL":"https:\/\/doi.org\/10.7573\/dic.212249","relation":{},"ISSN":["1740-4398"],"issn-type":[{"value":"1740-4398","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,27]]}}}